North America Biopsy Procedures
Outlook to 2023 provides key procedures data on the North America
Biopsy Procedures. The report provides procedure volumes within market
segments – Breast Biopsy Procedures, Colorectal Biopsy Procedures,
Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy
Procedures, Other Indications Biopsy Procedures, Prostate Biopsy
Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from
dynamic market forecast models. It uses epidemiology based models to
estimate and forecast the procedure volumes. The objective is to provide
information that represents the most up-to-date data of the industry
possible.
The epidemiology-based forecasting model
makes use of epidemiology data gathered from research publications and
primary interviews with physicians to establish the target patient
population and treatment flow patterns for individual diseases and
therapies. Using prevalence and incidence data and diagnosed and treated
population, the epidemiology-based forecasting model arrives at the
final numbers.
Extensive interviews are conducted with
key opinion leaders (KOLs), physicians and industry experts to validate
the procedure volumes.
Scope
- North America Biopsy Procedures volumes by segments – Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
- Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons To Buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.
No comments:
Post a Comment